- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05308017
Wolf 24 F vs. Storz 28 F Laser Sheath Size for HoLEP
Does Sheath Size Matter? Wolf 24 F vs. Storz 28 F Laser Sheath Size for Holmium Laser Enucleation of the Prostate
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients Males 18-89 undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms
Exclusion Criteria:
- Patients who lack decisional capacity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Richard Wolf 24F Laser scope
|
24F Laser with HoLEP
|
|
Active Comparator: Karl Storz 28F Laser scope
|
28 F Laser with HoLEP
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Surgery Time difference between the 24F laser scope and the 28F laser scope
Time Frame: Day 0
|
comparing operative time between the 24F and the 28F laser scope groups.
|
Day 0
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Surgeon evaluation of Laser scopes flow rate
Time Frame: Day 0
|
Internal survey within REDCap to be completed by the surgeon using the scope. The survey will ask the surgeon the following questions after every surgery 1) How was the flow through the scope? a. 1) Poor 2) Problematic 3) Mediocre 4) Adequate 5) Good |
Day 0
|
|
Surgeon evaluation of Laser scope visualization
Time Frame: Day 0
|
Internal survey within REDCap to be completed by the surgeon using the scope. The survey will ask the surgeon the following questions after every surgery 2) How was the visualization? a. 1) Poor 2) Problematic 3) Mediocre 4) Adequate 5) Good |
Day 0
|
|
Surgeon evaluation of Laser scope bladder injury
Time Frame: Day 0
|
Internal survey within REDCap to be completed by the surgeon using the scope. The survey will ask the surgeon the following questions after every surgery 3) Did bladder injury occur? a. 1) Yes 2) No |
Day 0
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU00215646
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Benign Prostatic Hypertrophy
-
Chong Kun Dang PharmaceuticalCompletedBenign Prostatic Hypertrophy (BPH)Korea, Republic of
-
San Carlo di Nancy HospitalElesta S.R.L.CompletedBenign Prostatic Hyperplasia | Benign Prostatic Hypertrophy | Benign Prostatic Hypertrophy With Outflow Obstruction | Prostate HyperplasiaItaly
-
Indiana Kidney Stone InstituteRichard Wolf Medical Instruments Corporation (RWMIC)CompletedBenign Prostatic Hypertrophy Requiring Surgical InterventionUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Not yet recruitingLower Urinary Tract Symptoms | Benign Prostate Hyperplasia | Benign Prostatic Hypertrophy With Outflow Obstruction
-
Boston Scientific CorporationCompletedProstatic Hyperplasia | Benign Prostatic Hyperplasia | Prostatic Hyperplasia, Benign | Prostatic Hypertrophy | Prostatic Hypertrophy, Benign | Adenoma, Prostatic | Prostatic Adenoma | RezumDominican Republic, Czechia, Sweden
-
Boston Scientific CorporationCompletedBenign Prostatic Hyperplasia | Prostatic Hyperplasia, Benign | Prostatic Hypertrophy | Prostatic Hypertrophy, Benign | Adenoma, Prostatic | Prostatic Adenoma | RezumDominican Republic
-
IMBiotechnologies Ltd.CompletedBenign Prostatic Hyperplasia | Benign Prostatic HypertrophyCanada
-
IRCCS Policlinico S. MatteoCompletedBenign Prostatic Hyperplasia | Benign Prostatic Hypertrophy With Outflow ObstructionItaly
-
American Medical SystemsCompletedBenign Prostatic Hyperplasia | BPH | Benign Prostatic Hypertrophy | Prostate Disease
-
Vantia LtdCompletedNocturia | Benign Prostatic Hypertrophy (BPH)Germany
Clinical Trials on Richard Wolf 24F Laser scope
-
Postgraduate Institute of Medical Education and...CompletedPleurisy With EffusionIndia
-
South Valley UniversityCompleted
-
Baylor College of MedicineCompleted
-
PhotocureJiangsu Yahong Meditech Co., Ltd aka Asieris; Richard Wolf GmbH; Tigermed-Jyton...Completed
-
Chelsea and Westminster NHS Foundation TrustRoyal College of Surgeons of EnglandUnknownThermography | Laser Doppler Blood Flow | Spectrophotometric Intracutaneous AnalysisUnited Kingdom
-
Oregon Health and Science UniversityRecruiting
-
Johns Hopkins UniversityActive, not recruitingNeural Tube Defects | Spinal Dysraphism | Chiari Malformation Type 2 | Myelomeningocele | Spina Bifida | Congenital AbnormalityUnited States
-
Baylor College of MedicineActive, not recruiting